Keywords: astrazeneca, rated, outperform, msdw, analysts, morgan, stanley

AstraZeneca rated outperform by MSDW

Article | 19 April 1999

Print This

Analysts at Morgan Stanley Dean Witter have initiated coverage ofAstraZeneca with an outperform rating and a 12-month price target of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in